Related Experiment Video
Updated: Jan 31, 2026

Comparative Analysis of Experimental Methods to Quantify Animal Activity in Caenorhabditis elegans Models of Mitochondrial Disease
Published on: April 4, 2021
Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
Masahiro Wakita1, Koyu Ito1,2, Kaho Fujii1
1Research Institute for Microbial Diseases (RIMD), The University of Osaka, Suita, Japan.
Abstract:
Cellular senescence contributes to aging and disease, and senolytic drugs that selectively eliminate senescent cells hold therapeutic promise. Although over 20 candidates have been reported, their relative efficacies remain unclear. Here we systematically compared 21 senolytic agents using a senolytic specificity index, identifying the Bcl-2 inhibitor ABT263 and the BET inhibitor ARV825 as most effective senolytics across fibroblast and epithelial senescence models. However, even upon extended treatment with these most potent senolytics, a proportion of senescent cells remained viable. We found that senolytic resistance was driven by maintenance of mitochondrial integrity through V-ATPase-mediated clearance of damaged mitochondria. Imposing mitochondrial stress via metabolic workload enhanced the senolytic efficacies of ABT263 and ARV825 in vitro, and in mouse models, ketogenic diet adoption or SGLT2 inhibition similarly potentiated ABT263-induced and ARV825-induced senolysis, reducing metastasis and tumor growth. These findings suggest that mitochondrial quality control is a key determinant of resistance to ABT263-induced and ARV825-induced senolysis, providing a possible framework for rational combination senotherapies.
Insights
Senolytic drugs target senescent cells to combat aging and disease. Combining potent senolytics like ABT263 with strategies that induce mitochondrial stress enhances their efficacy and reduces tumor growth.
Area of Science:
- Cellular and Molecular Biology
- Aging Research
- Oncology
Background:
- Cellular senescence is implicated in aging and various diseases.
- Senolytic drugs offer therapeutic potential by eliminating senescent cells.
- The comparative efficacy and resistance mechanisms of senolytic agents require further investigation.
Purpose of the Study:
- To systematically compare the efficacy of 21 senolytic agents.
- To identify mechanisms of resistance to senolytic drugs.
- To explore strategies for enhancing senolytic therapy effectiveness.
Main Methods:
- Comparative analysis of 21 senolytic agents using a senolytic specificity index.
- Investigation of senescent cell viability and mitochondrial integrity.
- In vitro and in vivo studies assessing the impact of mitochondrial stress on senolysis.
- Evaluation of ketogenic diet and SGLT2 inhibition in combination with senolytics.
Main Results:
- ABT263 (Bcl-2 inhibitor) and ARV825 (BET inhibitor) were identified as the most effective senolytics.
- Senolytic resistance is mediated by V-ATPase-dependent clearance of damaged mitochondria, maintaining mitochondrial integrity.
- Inducing mitochondrial stress through metabolic workload, ketogenic diet, or SGLT2 inhibition potentiated ABT263 and ARV825 efficacy.
- Combination therapy reduced metastasis and tumor growth in mouse models.
Conclusions:
- Mitochondrial quality control is a critical factor in resistance to senolysis.
- Targeting mitochondrial stress can overcome resistance to potent senolytic drugs like ABT263 and ARV825.
- This provides a framework for developing combination senotherapies to enhance treatment outcomes in aging and cancer.
Related Concept Videos
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Comparing the Survival Analysis of Two or More Groups
Animal Mitochondrial Genetics
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Self-Efficacy
Therapeutic Drug Monitoring: Drug Analysis Methods

